Literature DB >> 1496501

Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis.

R F Taylor1, D W Morgan, P S Nicholson, I S Mackay, M E Hodson, T L Pitt.   

Abstract

BACKGROUND: Pseudomonas aeruginosa infection is seldom eradicated in patients with cystic fibrosis despite intensive antipseudomonal treatment. Upper airway sites of infection may contribute to perpetuation of lower airways infection. This study was designed to find out which extrapulmonary sites are infected and whether the strains at these sites are identical to those in the lungs.
METHODS: Sputum and upper airway samples from 42 patients were cultured for P aeruginosa and stool samples from 20 patients were also tested. Nineteen isolates from sputum and extrapulmonary sites from four patients were genotyped with the pCM tox probe.
RESULTS: P aeruginosa was isolated from the sputum of 36 patients, 34 of whom had infection in the upper airways. Six of the 20 patients tested were positive for P aeruginosa in the stool. The nasopharynx was colonised in 30 patients, the oropharynx in 29, the middle meatus in 13, the external nares in six, and the inferior turbinate in four. Three of four patients tested had the same strain of P aeruginosa (a different one in each individual) in the sputum and the upper airways, and in two of the three the stool isolate was a different strain.
CONCLUSION: Most adults with cystic fibrosis and P aeruginosa pulmonary infection have upper airway reservoirs of the organism and strains from these sites are identical to those in the lungs.

Entities:  

Mesh:

Year:  1992        PMID: 1496501      PMCID: PMC463806          DOI: 10.1136/thx.47.6.426

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  Two simple media for the demonstration of pyocyanin and fluorescin.

Authors:  E O KING; M K WARD; D E RANEY
Journal:  J Lab Clin Med       Date:  1954-08

2.  Bacterial reservoirs in cystic fibrosis.

Authors:  C J Taylor; J McGaw; R Howden; B I Duerden; P S Baxter
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

3.  Clinical significance of tissue penetration of antibiotics in the respiratory tract.

Authors:  H P Lambert
Journal:  Scand J Infect Dis Suppl       Date:  1978

4.  Bacteriology of the maxillary sinuses in patients with cystic fibrosis.

Authors:  E D Shapiro; G J Milmoe; E R Wald; J B Rodnan; A D Bowen
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

5.  Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

Authors:  C Wolz; G Kiosz; J W Ogle; M L Vasil; U Schaad; K Botzenhart; G Döring
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

6.  Factors influencing pseudomonas colonization in cystic fibrosis.

Authors:  L L Kulczycki; R L Wientzen; T Heller; J A Bellanti
Journal:  Ann Allergy       Date:  1988-05

7.  Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation.

Authors:  D T Umetsu; R B Moss; V V King; N J Lewiston
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

8.  Acetamide broth for isolation of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  N M Kelly; F R Falkiner; C T Keane
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

9.  Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.

Authors:  J W Ogle; L B Reller; M L Vasil
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

10.  Molecular studies of Pseudomonas exotoxin A gene.

Authors:  M L Vasil; C Chamberlain; C C Grant
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.609

View more
  9 in total

1.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

2.  Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis.

Authors:  V Tsang; T L Pitt; M E Kaufmann; H Gaya; M E Hodson; M Yacoub
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

3.  Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.

Authors:  Susse Kirkelund Hansen; Martin Holm Rau; Helle Krogh Johansen; Oana Ciofu; Lars Jelsbak; Lei Yang; Anders Folkesson; Hanne Østergaard Jarmer; Kasper Aanæs; Christian von Buchwald; Niels Høiby; Søren Molin
Journal:  ISME J       Date:  2011-06-30       Impact factor: 10.302

4.  Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis.

Authors:  Suzie Hyeona Kang; Camila Degen Meotti; Karine Bombardelli; Otávio Bejzman Piltcher; Paulo de Tarso Roth Dalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-18       Impact factor: 2.503

Review 5.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

6.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

Review 7.  Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Authors:  Maria E Møller; Mikkel C Alanin; Christian Grønhøj; Kasper Aanæs; Niels Høiby; Christian von Buchwald
Journal:  Am J Rhinol Allergy       Date:  2017-09-01       Impact factor: 2.467

8.  Defective fluid secretion from submucosal glands of nasal turbinates from CFTR-/- and CFTR (ΔF508/ΔF508) pigs.

Authors:  Hyung-Ju Cho; Nam Soo Joo; Jeffrey J Wine
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

9.  Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.

Authors:  Ulrike Müller; Julia Hentschel; Wibke K Janhsen; Kerstin Hünniger; Uta-Christina Hipler; Jürgen Sonnemann; Wolfgang Pfister; Klas Böer; Thomas Lehmann; Jochen G Mainz
Journal:  Mediators Inflamm       Date:  2015-06-21       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.